PFIZER INC

PFE | NYSE | CIK: 0000078003 | SIC: 2834 Pharmaceutical Preparations | active
New York, NY
Pfizer Inc. is a global biopharmaceutical company that discovers, develops, manufactures, and commercializes medicines and vaccines. Key products include Comirnaty (COVID-19 vaccine), Paxlovid (COVID-19 oral treatment), Prevnar family (pneumococcal vaccines), Vyndaqel family (transthyretin amyloid cardiomyopathy), and oncology products including antibody-drug conjugates acquired through Seagen. Pfizer operates across developed and emerging markets worldwide, with commercial operations spanning internal and alliance-based product portfolios.
developed-markets-(western-europe,-japan,-canada,-australia,-south-korea,-etc.)emerging-markets-(asia-ex-japan/south-korea,-latin-america,-eastern-europe,-africa,-middle-east,-turkey)united-statesoncologyvaccinesinternal-medicinecovid-19-therapeutics-and-vaccinescurrent-good-manufacturing-practices-(cgmp)mrna-(messenger-ribonucleic-acid)-platformbiologics-license-application-(bla)new-drug-application-(nda)emergency-use-authorization-(eua)
AI agents: Get this data as structured JSON (~200 tokens):
https://origin.rootz.global/api/company/PFE
Profile | Timeline | SEC Filings | People

Products

NameTypeDescription
ComirnatyservicemRNA COVID-19 vaccine, first authorized in the U.S. in December 2020 under EUA.
PaxlovidserviceOral COVID-19 treatment (nirmatrelvir/ritonavir tablets) authorized under EUA for high-risk patients.
Prevnar familyservicePneumococcal vaccines including Prevnar 20/Prevenar 20 and Prevnar 13/Prevenar 13 for pediatric and adult use.
Vyndaqel familyserviceIncludes Vyndaqel, Vyndamax, and Vynmac for treatment of transthyretin amyloid cardiomyopathy (ATTR-CM).
LipitorserviceGlobally recognized branded cholesterol medication, formerly part of the Upjohn Business.
Antibody-Drug Conjugates (ADC)platformOncology platform acquired through Seagen Inc., targeting cancer treatment.

Partnerships

PartnerTypeDescription
BioNTechdevelopmentCollaboration related to Comirnaty mRNA COVID-19 vaccine development and commercialization.
AstellasstrategicAlliance agreement for co-promotion of products.
ArvinasdevelopmentCollaboration partnership referenced in alliance agreements.
GenmabdevelopmentCollaboration partnership referenced in alliance agreements.
ViiV HealthcarestrategicAlliance partnership referenced in Pfizer's collaboration agreements.
AbingworthstrategicPartnership referenced in Pfizer's collaboration and business activities.
Blackstone Life SciencesstrategicPartnership referenced in Pfizer's collaboration agreements.
Pierre FabrestrategicCollaboration referenced in Pfizer's alliance and co-promotion agreements.
MetseradevelopmentPartnership referenced in Pfizer's collaboration agreements.
Nimbus TherapeuticsdevelopmentCollaboration partnership referenced in Pfizer's alliance agreements.

SEC Filings

View all SEC EDGAR filings: EDGAR Company Page

Structured filing index: /api/company/PFE/filings

Origin — Data Provenance
This profile was extracted from SEC EDGAR filings (PEM-signed by sec.gov).
Every API response includes a cryptographic origin leaf for chain-of-custody tracking.
AI Discovery Document | Registry Metrics | GitHub